https://jamanetwork.com/journals/jama/article-abstract/2821290
Medications for Obesity: A Review
JAMA. 2024 Aug 20;332(7):571-584
Kimberly A Gudzune, Robert F Kushner
https://onlinelibrary.wiley.com/doi/10.1155/2024/8056440
A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity
J Obes. 2024 May 10:2024:8056440.
Ibrahim Abdullah Bin Ahmed
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00388-1/abstract
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Lancet Diabetes Endocrinol. 2024 Mar;12(3):184-195.
Yiming Mu, Xiaolei Bao, Freddy G Eliaschewitz, Morten Rix Hansen, Bom Taeck Kim, Anna Koroleva, Ronald C W Ma, Tao Yang, Ning Zu, Ming Liu; STEP 7 Study Group
https://www.nature.com/articles/s41366-024-01473-y
What is the pipeline for future medications for obesity?
Int J Obes (Lond). 2024 Feb 1.
Melson E, Ashraf U, Papamargaritis D, Davies MJ.